GenScript Biotech Corporation, founded in 2002 and publicly traded (Stock Code: 1548.HK), is a leading global biotechnology group with a strong presence in North America, Europe, Greater China, and Asia Pacific. The company specializes in gene synthesis technology and operates across four major business categories: Life Science CRO, enzyme and synthetic biology products, biologics development and manufacturing, and cell therapy. GenScript is dedicated to enhancing human and environmental health through biotechnology. Its subsidiary, ProBio, offers a comprehensive biopharmaceutical R&D and production platform focused on cell and gene therapy drugs, vaccines, and biopharmaceutical discovery, providing end-to-end CDMO services to clients worldwide.